Nestle Sa ADR (NSRGY)

$93.23 +0.22 (0.23%)
Market Cap 239.64B
Revenue (ttm) 104.18B
Net Income (ttm) 12.36B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 17.08
Profit Margin 11.87%
Debt to Equity Ratio 1.73
Volume 451,400
Avg Vol 656,206
Day's Range N/A - N/A
Shares Out 2.58B
Stochastic %K 89%
Beta 0.49
Analysts Sell
Price Target $103.23

Company Profile

Nestlé S.A., together with its subsidiaries, operates as a food and beverage company. It operates through Zone North America; Zone Europe; Zone Asia, Oceania and Africa; Zone Latin America; Zone Greater China; Nestlé Health Science; and Nespresso segments. The company offers water under the Acqua Panna, Nestlé Pure Life, Perrier, S.Pellegrino, Sanpellegrino, and other local brands; and chocolate and confectionery products under the Aero, Baci Perugina, KitKat, Milkybar, Smarties, and other local...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 41 21 924 1111
Address:
Avenue Nestlé 55, Vevey, Switzerland
Numbersandfacts
Numbersandfacts Sep. 29 at 3:39 PM
$MCRB Danone, one of Nestle $NSRGY rivals and competitors, has acquired the akkermansia company. They understand the microbiome is the future of food, medicines and supplements. If Nestle doesn't want Seres its patents and pipeline, I say the admin should reach out to Danone!
0 · Reply
SenefAS
SenefAS Sep. 24 at 11:31 AM
Canaccord raised the price target on Seres Therapeutics to $22 from $14 and keeps a Buy rating on the shares. The firm noted the FDA provided feedback on Seres’ proposed Phase 2 SER-155 study in bloodstream infections, which could aid in partnership discussions $MCRB $XBI $NSRGY
0 · Reply
Numbersandfacts
Numbersandfacts Sep. 18 at 3:20 PM
$MCRB Danone has bought the Akkermansia company. $NSRGY your move!
0 · Reply
StreetwiseReports
StreetwiseReports Sep. 16 at 8:34 PM
Change of CEO at Nestle With Stock Undervalued https://ow.ly/1JPt50WXNCt Global Analyst Adrian Day shares a brief update on developments at three companies on his list. $NESN $NSRGY $OGN.V $OGNNF $PAAS
0 · Reply
Thepark88
Thepark88 Sep. 16 at 11:31 AM
$LLY $MCRB $NSRGY $SGTX more similarities, same as poseida, sit tight
1 · Reply
SenefAS
SenefAS Sep. 16 at 9:59 AM
Did you see similarities ? 🚨 Before the buyout of Sigilon $SGTX a company owned by Flagship the same company behind Seres $MCRB There was a corporate split and the company was bought out a month later... $NSRGY $NESN.SW $LLY
0 · Reply
SenefAS
SenefAS Sep. 15 at 8:38 AM
$IBB $MCRB $NSRGY $XBI Soon the big announcement ? 📣
0 · Reply
SenefAS
SenefAS Sep. 13 at 4:21 AM
📊 What the chart shows: •Strong rally from ~$6.20 in early April to ~$17.40 by early September (+181%). 📊 Key insights from the chart: $MCRB : ◦April 2025: ~$6.20 → Early Sept 2025: ~$17.40 (+181%) ◦Spiked above $22 intraday after the Sept 5 Nestlé $41/share bid the Sept 5 Nestlé $41/share bid before settling lower. $NSRGY #biotech $XBI $IBB Outperformed the biotech sector dramatically. Trend phases: •Light green zone = sustained uptrend •Light gray zone = consolidation •Salmon zone = September spike on Nestlé news And you still not believe in the BO 🙃
0 · Reply
SenefAS
SenefAS Sep. 10 at 9:02 PM
Did you have see that all the game player in the food industry buy a microbiome company the last in date it’s Danone : https://www.danone.com/newsroom/press-releases/acquisition-of-the-akkermansia-company.html $MCRB $DANOY $NSRGY $UL
2 · Reply
SenefAS
SenefAS Sep. 10 at 7:34 PM
Whispers on Wall Street: Nestlé reportedly eyeing a $760M takeover of Seres Therapeutics $MCRB 💊 SER‑155: cutting infection risk by 77% in trials 🏆 Breakthrough Therapy status from the FDA 📈 Stock already surging on the chatter (300% in 3 month) If Nestlé pulls the trigger, this could be one of the biggest microbiome deals of the decade. #Biotech #MCRB #Nestle #Investing #FDA #M&A $NSRGY
0 · Reply
Latest News on NSRGY
No data available.
Numbersandfacts
Numbersandfacts Sep. 29 at 3:39 PM
$MCRB Danone, one of Nestle $NSRGY rivals and competitors, has acquired the akkermansia company. They understand the microbiome is the future of food, medicines and supplements. If Nestle doesn't want Seres its patents and pipeline, I say the admin should reach out to Danone!
0 · Reply
SenefAS
SenefAS Sep. 24 at 11:31 AM
Canaccord raised the price target on Seres Therapeutics to $22 from $14 and keeps a Buy rating on the shares. The firm noted the FDA provided feedback on Seres’ proposed Phase 2 SER-155 study in bloodstream infections, which could aid in partnership discussions $MCRB $XBI $NSRGY
0 · Reply
Numbersandfacts
Numbersandfacts Sep. 18 at 3:20 PM
$MCRB Danone has bought the Akkermansia company. $NSRGY your move!
0 · Reply
StreetwiseReports
StreetwiseReports Sep. 16 at 8:34 PM
Change of CEO at Nestle With Stock Undervalued https://ow.ly/1JPt50WXNCt Global Analyst Adrian Day shares a brief update on developments at three companies on his list. $NESN $NSRGY $OGN.V $OGNNF $PAAS
0 · Reply
Thepark88
Thepark88 Sep. 16 at 11:31 AM
$LLY $MCRB $NSRGY $SGTX more similarities, same as poseida, sit tight
1 · Reply
SenefAS
SenefAS Sep. 16 at 9:59 AM
Did you see similarities ? 🚨 Before the buyout of Sigilon $SGTX a company owned by Flagship the same company behind Seres $MCRB There was a corporate split and the company was bought out a month later... $NSRGY $NESN.SW $LLY
0 · Reply
SenefAS
SenefAS Sep. 15 at 8:38 AM
$IBB $MCRB $NSRGY $XBI Soon the big announcement ? 📣
0 · Reply
SenefAS
SenefAS Sep. 13 at 4:21 AM
📊 What the chart shows: •Strong rally from ~$6.20 in early April to ~$17.40 by early September (+181%). 📊 Key insights from the chart: $MCRB : ◦April 2025: ~$6.20 → Early Sept 2025: ~$17.40 (+181%) ◦Spiked above $22 intraday after the Sept 5 Nestlé $41/share bid the Sept 5 Nestlé $41/share bid before settling lower. $NSRGY #biotech $XBI $IBB Outperformed the biotech sector dramatically. Trend phases: •Light green zone = sustained uptrend •Light gray zone = consolidation •Salmon zone = September spike on Nestlé news And you still not believe in the BO 🙃
0 · Reply
SenefAS
SenefAS Sep. 10 at 9:02 PM
Did you have see that all the game player in the food industry buy a microbiome company the last in date it’s Danone : https://www.danone.com/newsroom/press-releases/acquisition-of-the-akkermansia-company.html $MCRB $DANOY $NSRGY $UL
2 · Reply
SenefAS
SenefAS Sep. 10 at 7:34 PM
Whispers on Wall Street: Nestlé reportedly eyeing a $760M takeover of Seres Therapeutics $MCRB 💊 SER‑155: cutting infection risk by 77% in trials 🏆 Breakthrough Therapy status from the FDA 📈 Stock already surging on the chatter (300% in 3 month) If Nestlé pulls the trigger, this could be one of the biggest microbiome deals of the decade. #Biotech #MCRB #Nestle #Investing #FDA #M&A $NSRGY
0 · Reply
SenefAS
SenefAS Sep. 10 at 2:04 PM
$MCRB $NSRGY I just missed on this time line to mention on the board nomination of Dr Dr. Hans-Juergen Woerle the CMO of Nestle Health and yes of course still none nomination of a CMO at Seres… 😉
0 · Reply
SenefAS
SenefAS Sep. 9 at 4:20 PM
$IBB $MCRB $NSRGY $XBI Don’t Panic read this post and do your own DD…
1 · Reply
SenefAS
SenefAS Sep. 8 at 11:10 AM
I hope some analysts ask today about that offer: Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will attend the upcoming H.C. Wainwright Global Investment Conference in New York City and will present a company overview at 3:00 p.m. ET on September 8, 2025. $MCRB $NSRGY $XBI $IBB
1 · Reply
SenefAS
SenefAS Sep. 8 at 8:41 AM
Finally Seres Therapeutics received offers of Nestlé for 41$ + 35$ CVR reported by Swiss media @InsideParade & @awp_de that’s look not bad :) Probably the last time to buy more ? $MCRB $NSRGY #biotech $XBI $IBB
2 · Reply
SwissBull7
SwissBull7 Sep. 7 at 10:11 PM
$LKNCY & $NSRGY 5 Brand innovations leading the way at Nestlé Bernard Meunier Executive Vice President Head of Strategic Business Units and Marketing and Sales https://www.nestle.com/stories/brand-innovation-coffee-pet-food-leading
1 · Reply
SenefAS
SenefAS Sep. 4 at 9:17 AM
Make your own DD and you understand Since 2015, Nestlé Health Science has invested big in Seres Therapeutics: 2015 $66.5M + $30M 💵 2021 $175M + $125M 📈 2024 $175M + $18M 🔄 2025 $50M + $25M 💰 Total so far: ~$664.5M Potential: +$275M milestones #biotech #Nestle $NSRGY $MCRB
1 · Reply
Kascnef82
Kascnef82 Sep. 3 at 5:35 PM
$NSRGY https://www.linkedin.com/posts/philipp-navratil-5b247632_nestlaez-activity-7368915670668910593-evGi?utm_medium=ios_app&rcm=ACoAAADR-vgBD0fgnFy5czMycFSccrsd15HmTUI&utm_source=social_share_send&utm_campaign=copy_link
0 · Reply
Equivoxsocial
Equivoxsocial Sep. 2 at 2:06 PM
💘Love is in the air 🍫Chocolate everywhere But this company is in disarray Because the CEO's _ _ _ _ _ _! $NSRGF $NSRGY #chocolate As a shareholder, would you support ousting a CEO for this behavior? What if the stock was performing well? https://finance.yahoo.com/news/nestle-investors-face-more-turbulence-040820890.html
0 · Reply
jaydongs
jaydongs Sep. 2 at 8:01 AM
$NSRGY Nestle dismisses CEO Freixe after romantic relationship with staffer.
0 · Reply
enwerd999
enwerd999 Sep. 2 at 7:13 AM
$NSRGY God forbid a CEO gets some pussy on the side lmao
0 · Reply
Boson_reads
Boson_reads Sep. 2 at 5:46 AM
$NSRGY Nestlé Retail Traders Stay Cautious After CEO Laurent Freixe Ousted Over Romance Scandal https://stocktwits.com/news-articles/markets/equity/nestle-retail-traders-stay-cautious-after-ceo-laurent-freixe-ousted-over-romance-scandal/chv60GoRdn2
0 · Reply
Okadarlan
Okadarlan Sep. 1 at 10:10 PM
$NSRGY hmm sell tomorrow rebuy at 80s \/ ?
0 · Reply